Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Iscience|February 28, 2020
Engineering Cellular Biosensors with Customizable Antiviral Responses Targeting Hepatitis B VirusSatoko Matsunaga, Sundararaj S Jeremiah, Kei Miyakawa, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 11, 2006
Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3bAkiko Tsumura, Tomohiro Hayakawa, Yuichi Kumaki, et al.
Journal of Virology|September 10, 2010
Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoformsTakayuki Hishiki, Yuko Shimizu, Reiri Tobita, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 20, 2014
Murine Herc6 Plays a Critical Role in Protein ISGylation In Vivo and Has an ISGylation-Independent Function in Seminal VesiclesKei-ichiro Arimoto, Takayuki Hishiki, Hiroshi Kiyonari, et al.
Journal of Virology|April 17, 2009
Genetic analysis of hepatitis C virus with defective genome and its infectivity in vitroKazuo Sugiyama, Kenji Suzuki, Takahide Nakazawa, et al.
Oncotarget|September 4, 2018
Circulating microRNA-636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavirAsahiro Morishita, Hirohito Yoneyama, Hisakazu Iwama, et al.
International Journal of Molecular Sciences|July 14, 2018
Serum miRNAs Predicting Sustained HBs Antigen Reduction 48 Weeks after Pegylated Interferon Therapy in HBe Antigen-Negative PatientsKoji Fujita, Shima Mimura, Hisakazu Iwama, et al.
Biochemistry and Biophysics Reports|July 20, 2018
Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251Youki Ueda, Weilin Gu, Hiromichi Dansako, et al.
Pageof 17